CN Patent

CN116583527A — 用于64Cu-DOTATATE放大规模的放射性标记和制剂

Assigned to Kurim Usa LLC · Expires 2023-08-11 · 3y expired

What this patent protects

本公开涉及一种创建稳健的程序的方法，所述程序能够提供商业量的放射性诊断剂，所述放射性诊断剂适合与正电子发射断层成像(PET)一起用于成年患者中生长抑素受体阳性神经内分泌肿瘤(NET)的定位。

USPTO Abstract

本公开涉及一种创建稳健的程序的方法，所述程序能够提供商业量的放射性诊断剂，所述放射性诊断剂适合与正电子发射断层成像(PET)一起用于成年患者中生长抑素受体阳性神经内分泌肿瘤(NET)的定位。

Drugs covered by this patent

Patent Metadata

Patent number: CN116583527A
Jurisdiction: CN
Classification: —
Expires: 2023-08-11
Drug substance claim: No
Drug product claim: No
Assignee: Kurim Usa LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.